Search
Indole-3-Glycerol Phosphate
go.drugbank.com/drugs/DB04143ExperimentalCategories: Compounds used in a research, industrial, or household settingBromopyruvate
go.drugbank.com/drugs/DB17135ExperimentalCategories: Compounds used in a research, industrial, or household settingMVA3000
go.drugbank.com/drugs/DB05040ExperimentalMVA3000 is an attenuated smallpox vaccine that is being developed for use in people for whom the traditional smallpox vaccine is contraindicated, such as patients with disorders of the immune system or
Demeclocycline
go.drugbank.com/drugs/DB00618ApprovedA tetracycline analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time.
INCB7839
go.drugbank.com/drugs/DB05033InvestigationalIt has shown promising clinical activity in heavily pretreated, refractory breast cancer patients.
AG-702
go.drugbank.com/drugs/DB05836ExperimentalHSPs are present in all cells in all life forms from bacteria to mammals, and their structure and function are similar across these diverse life forms.
Fontolizumab
go.drugbank.com/drugs/DB05111InvestigationalFontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
ONT-093
go.drugbank.com/drugs/DB14069ExperimentalIn pre-clinical studies, ONT-093 could inhibit P-gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics. … ONT-093 is an orally bioavailable inhibitor of P-glycoprotein (P-gp).
Nirogacestat
go.drugbank.com/drugs/DB12005ApprovedInvestigationalDesmoid tumors are typically characterized by aberrant activation in Notch signaling. … It was previously granted breakthrough therapy, fast track, and orphan drug designations for the treatment of desmoid tumors, and the final approval was based on positive results obtained in the Phase
Pozelimab
go.drugbank.com/drugs/DB15218ApprovedInvestigationalautoimmune hemolysis that are often observed in CHAPLE disease. … CD55-deficient protein-losing enteropathy (PLE), or CHAPLE disease, is an ultra-rare hereditary disease, with fewer than 100 patients diagnosed worldwide or fewer than 10 patients in the US.